

Fabricator: Dragon Pharma, Europe
Unit: x1 vial
Strength: 5 mg/ml
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Dragon Pharma TB 500 is a synthetic peptide modeled after Thymosin Beta-4 (Tβ4), a naturally occurring protein present in nearly all mammalian cells. This laboratory-grade peptide is of interest in research settings due to its potential roles in tissue regeneration, inflammation modulation, and cellular repair. While promising in preclinical models, Dragon Pharma TB 500 remains for research use only and is not approved for clinical applications.
Dragon Pharma TB 500 exerts its effects primarily through actin regulation, a key protein involved in cell structure, migration, and tissue healing. By upregulating actin, TB 500 may support:
Preclinical research with Dragon Pharma TB 500 has explored its potential roles in:
All findings are based on laboratory studies. Dragon Pharma TB 500 is not approved for human or veterinary use.
Dragon Pharma TB 500 is intended for laboratory research use only. It has not been evaluated by the FDA, EMA, or any other regulatory agency for safety, efficacy, or human administration. Researchers are responsible for compliance with all applicable regulations. This product is not intended to diagnose, treat, cure, or prevent any disease.
Q1: Is Dragon Pharma TB 500 approved for human use?
A: No, it is for research purposes only and not approved for clinical or therapeutic use.
Q2: How does Dragon Pharma TB 500 differ from natural Thymosin Beta-4?
A: It is a synthetic fragment designed for research stability and reproducibility, while Tβ4 is the full-length naturally occurring peptide.
Q3: How should Dragon Pharma TB 500 be stored?
A: Store at -20°C while lyophilized. After reconstitution, refrigerate at 2–8°C and use promptly in experiments.
Q4: Is it legal to purchase Dragon Pharma TB 500?
A: It can be purchased for research use in most jurisdictions, subject to local regulations.
Please log in to write TB 500 5mg review.